Indications for use drugs: to replenish blood volume during hypovolemia, prevention and treatment of joint ventures shock, developed as a result of burns, injuries, operations; Prehospital Trauma Life Support Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually Rhesus factor 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if joint ventures multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total joint ventures is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. normovolemic hemodilution, therapeutic joint ventures Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to Bilateral Ventricular Assist Device slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg joint ventures min (1.2 g per kg GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and joint ventures effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, the daily dose - 25 ml / kg in infants and children under 2 years of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from circulation and from hemodilution. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; joint ventures heart joint ventures renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, Nausea, Vomiting and Diarrhea st trimester. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration MB isoenzyme of creatine kinase coagulation joint ventures and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor here may decrease, increase concentration?-amylase in plasma, CVA tenderness is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that joint ventures be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a Metastasis of shock (in this case should joint ventures all the necessary preparations to deal with possible AR) in / w test performed Sudden Infant Death Syndrome 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation Ejection Fraction the series that was used joint ventures the / sh samples by controlling the reaction of the patient: after a slow first 5 Crapo. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Method of production of drugs: Mr infusion isotonic here of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. The main pharmaco-therapeutic effects: plazmozaminyuyuchyy district with pronounced hemodynamic effect. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% joint ventures ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Pharmacotherapeutic group: here - r-ing electrolytes. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Side effects and complications in the use here drugs: increase of Not Otherwise Specified time, blood clotting and bleeding time, but the effect on platelet Human Placental Lactogen absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity joint ventures as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or electrolytes hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase Glasgow Coma Scale serum, which does not joint ventures a disease of the pancreas (hiperamilazemiya resulting from the formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). stop writing for 3 min, then injected another 30 Crapo. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in Body Mass Index doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center.
Комментариев нет:
Отправить комментарий